TODAY'S HEADLINES
On the final day of the 72nd Annual Meeting of the American Academy of Dermatology, clinicians shared clinical pearls regarding psoriasis comorbidities, isotretinoin dosing for acne and how to treat patients with body dysmorphic disorder. » More
|
A new study strongly links pulmonary complications to survival rates among scleroderma patients. » More
|
ADVERTISEMENT
Current and emerging therapies for psoriatic arthritis
Symptoms of psoriatic arthritis include inflammation in the joints and excessive production of skin cells. Learn about treatment options to help reduce these symptoms in your patients. View our psoriatic arthritis topic-based resource center and Learn More.
|
ADVERTISEMENT
Learn how your EHR can help with ICD-10
This free webinar, presented by Dermatology Times, shows you how to establish an implementation plan using an EHR vendor as a partner—so you can make a smooth transition to ICD-10 without falling short on workflow Click here to register. »
|
The Food and Drug Administration has approved an oral medication, Otezla (apremilast, Celgene) for the treatment of adult patients with active psoriatic arthritis. » More
|
|
|